Uta Francke, Val Sheffield, Kevin Campbell, Howard Worman, Benjamin Tycko

Nov 13, 2017

MNG Laboratories has appointed five individuals to its scientific advisory board. They are Uta Francke, Val Sheffield, Kevin Campbell, Howard Worman, and Benjamin Tycko. 

Francke is a professor emerita of genetics at Stanford University, while Sheffield is a professor of pediatrics and ophthalmology, and director of the division of medical genetics at the University of Iowa Carver College of Medicine.

Campbell is an investigator at the Howard Hughes Medical Institute, and chair and department executive officer in the department of molecular physiology and biophysics at the University of Iowa Carver College of Medicine. Worman is a professor of medicine and pathology and cell biology at the College of Physicians and Surgeons at Columbia University, while Tycko is senior scientist in the department of biomedical reearch, division of genetics and epigenetics at Hackensack University Medical Center. 

More Like This

May 25, 2018

Cynthia Collins

DermTech, a developer of non-invasive molecular dermatology tests, has appointed Cynthia Collins to its board of directors. Collins most recently served as CEO of Human Longevity. She has also been CEO/GM of GE Healthcare's cell therapy business, lab businesses, and Clarient Diagnostics. Prior to GE, Collins was president and CEO of GenVec. Before that she was group vice president for the cellular analysis business at Beckman Coulter. She has also held executive positions with Sequoia Pharmaceuticals and Clinical Micro Sensors, a subsidiary of Motorola.

May 24, 2018

Michael Sanderson

Michael Sanderson has been appointed CEO of PierianDx and director of the company's board. Sanderson has more than 25 years in the healthcare industry, mostly in healthcare analytics and big data. Most recently he has been a consultant focused on health IT and analytics, according to his LinkedIn profile. He was previously president and cofounder of RemitData.

May 23, 2018

Mike Nolan

Freenome has hired Mike Nolan as its chief commercial officer. In his new position, Nolan will be responsible for bringing Freenome's first AI-generated, genomic cancer screening test, a blood test for colorectal cancer, to market. Most recently, Nolan was senior vice president of commercial operations at Foundation Medicine. Overall, he has more than 25 years of experience in strategic management and commercial leadership at companies such as Thermo Fisher Scientific, Life Technologies, Luminex, and Roche Diagnostics.

May 22, 2018

Steve Ayer

TriCore Reference Laboratories announced the appointment of Steve Ayer as chief information officer as well as CEO of the company's The Rhodes Group, TriCore's healthcare software and analytics subsidiary. Ayer has served as TriCore's interim CIO for the past several months.

May 18, 2018

William Denman

William Denman, chief medical officer and founding member of Premaitha Health, has stepped down as director and consultant to the company.

May 17, 2018

Helen Torley

Quest Diagnostics announced that Helen Torley was elected to serve as a director during the company's 2018 annual meeting of stockholders, expanding the board of directors to 10 members. Torley had been president, CEO and director of Halozyme Therapeutics since 2014. She previously served as executive vice president and chief commercial officer for Onyx Pharmaceuticals, as vice president and general manager for Amgen's US bone health and nephrology business, and in various senior management positions at Bristol-Myers Sqibb and Sandoz/Novartis. She was formerly in medical practice as a senior registrar in rheumatology at the Royal Infirmary in Glascow, Scotland.

May 16, 2018

John Potthoff

John Potthoff has been appointed to the board of Chembio Diagnostics. He is currently CEO of Elligo Health Research. Prior to that, he was CEO of Theorem Clinical Research. Potthoff also is on the boards of Advarra and SynteractHCR. 

May 15, 2018

Rolland Carlson, Tanja Dowe, Katleen Verleysen

Immunexpress has appointed Rolland Carlson, Tanja Dowe, and Katleen Verleysen to its board. The company also noted that Bea Arnold has stepped down from the board after a three-year tenure.

Carlson was appointed CEO of Immunexpress last month, and previously served as president and CEO at both WaferGen Biosystems and Asuragen. Dowe currently serves as CEO of Debiopharm Innovation Fund, the strategic corporate fund of Debiopharm Group. Verleysen is CEO of CellSeeQ. Prior to that, she held various positions at Pronota, including CEO and chief operating officer.

May 14, 2018

Peter Knight

Peter Knight has joined Bioaffinity Technologies's board. Knight founded investment firm Generation Investment Mangement with Al Gore and David Blood. Prior to that, he was a managing director at Met West Financial. He was also general counsel at Medicis Pharmaceutical, and he started his career at the Antitrust Division of the US Department of Justice. He later was chief of staff to Al Gore. 

May 11, 2018

Bruce Walton

Aurora Diagnostics named Bruce Walton its president. He will also continue as Aurora's COO, a position he has had since 2015 when he was also named the company's executive vice president. Walton joined Aurora in 2009.

May 09, 2018

Gail Miller

Gail Miller has been appointed the chair of Intermountain Healthcare's board, succeeding Scott Anderson, who stepped down after completing his six-year term as the chair. He remains on the board as chair emeritus.

Miller joined Intermoutain's board in 2013 and serves on several committees, including the executive committee and the community relations committee. She is the owner of the Larry H. Miller Group of Companies and chair of its board. 

May 08, 2018

Stephanie Bywater

Stephanie Bywater has been appointed chief compliance officer at NeoGenomics. Her appointment became effective May 1, and she replaces Steven Jones, who will remain an executive vice president and board member at the company. Jones and NeoGenomics reached an agreement in November 2016 where he would reduce his time commitment to the firm, effective May 1 2018.

Bywater has been compliance officer at NeoGenomics since May 2017 when she joined the firm. She was previously global compliance operations and Americas compliance officer at Varian Medical Systems. Before that, she was the compliance and prvacy officer for Myriad Genetics. 

May 08, 2018

Michael Stocum

Michael Stocum has stepped down as CEO of Inivata "to pursue other interests," according to the company. Inivata said it has initiated a search for a new CEO.

May 08, 2018

Laurie Goodman

Laurie Goodman has been promoted to interim CEO of ClearLight Diagnostics, replacing Sarah McCurdy, who resigned as CEO. Goodman will also continue to serve as the company's CSO.  

May 04, 2018

Roberto Cuca

OraSure Technologies said that Roberto Cuca has been appointed its CFO, effective June 8. He replaces Ronald Spair, who is retiring from OraSure. Cuca will initially be a senior advisor to the company until June 8. He has been senior vice president and CFO at Trevena since 2013. Prior to that, he held various leadership positions in the finance organization of Endo Health Solutions.